Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpainsymman.2019.11.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An adaptive Bayesian randomized controlled trial of traditional Chinese medicine in progressive pulmonary fibrosis: Rationale and study design.
J Integr Med
January 2025
School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing 100029, China; International Acupuncture and Moxibustion Innovation Institute, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address:
Progressive pulmonary fibrosis (PPF) is a progressive and lethal condition with few effective treatment options. Improvements in quality of life for patients with PPF remain limited even while receiving treatment with approved antifibrotic drugs. Traditional Chinese medicine (TCM) has the potential to improve cough, dyspnea and fatigue symptoms of patients with PPF.
View Article and Find Full Text PDFAcupuncture, an increasingly popular alternative medical therapy, has heightened the demand for information on its safety profile. This is a case report involving a 28-year-old female who presented with intense right-sided chest pain and breathlessness after an acupuncture session where needles were inserted into her chest wall. The immediate medical evaluation revealed a tension pneumothorax with radiographic evidence of a mediastinal shift, compelling, urgent intervention via chest tube insertion.
View Article and Find Full Text PDF[Clinical efficacy observation of heat-sensitive moxibustion combined with intrapleural perfusion of cisplatin in treatment of malignant pleural effusion].
Zhen Ci Yan Jiu
November 2024
Acupuncture Rehabilitation Department, Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550003, China.
Objectives: To investigate the clinical efficacy of heat-sensitive moxibustion combined with intrapleural perfusion of cisplatin in comparison with simple intrapleural perfusion of cisplatin on malignant pleural effusion (MPE).
Methods: Forty patients with MPE, in compliance with the inclusion criteria, were randomly divided into an observation group (20 cases) and a control group (20 cases). In the control group, cisplatin solution (60 mg/m) was injected into the thoracic cavity after pleural drainage under B-ultrasound positioning, once a week for 4 weeks.
The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea.
Med Rev (2021)
October 2024
Department of Rehabilitation Medicine, China-Japan Friendship Hospital, Beijing, China.
Dyspnea is a subjective sensation often described as a feeling of respiratory effort, tightness, or air hunger. The underlying mechanisms of this symptom are multifaceted and involve factors such as respiratory centers, cardiovascular system, airways, neuromuscular components, and metabolic factors, although not fully elucidated. The classical theory of imbalance between inspiratory neural drive (IND) and the simultaneous dynamic responses of the respiratory system posits that the disruption of a normal and harmonious relationship fundamentally shapes the expression of respiratory discomfort.
View Article and Find Full Text PDFArticle Synopsis
- Chronic obstructive pulmonary disease (COPD) leads to ongoing issues like breathing difficulties, cough, and fatigue, significantly affecting patients’ quality of life and longevity, especially during acute exacerbations.
- Moving cupping therapy, a technique from traditional Chinese medicine, involves applying negative pressure to the skin and is suggested as a complementary treatment for acute exacerbations of COPD.
- The article evaluates the effectiveness of this therapy using health surveys and assessments, indicating that it could be a viable, cost-effective non-drug option for improving symptoms and overall well-being in COPD patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!